Experimental anti-depression drug may also be useful in treating alcohol use disorder Investigational, clinical-stage antidepressant MAP4343 shown to reduce alcohol intake in a mouse model of alcoholism.
January 30, 2023
LA JOLLA, CA An experimental antidepressant compound with a potentially unique mechanism of action may also be effective against alcohol use disorder, according to a preclinical study from Scripps Research.
In the study, which appeared Jan. 20, 2023, in Neuropsychopharmacology, researchers found that several weeks of treatment with the molecule MAP4343 reversed excessive alcohol intake in mice that modeled this condition.
MAP4343, a steroid-type molecule, is currently being investigated in clinical trials as an antidepressant, though its probable mechanism of action which involves modulating structural proteins in cells is unlike that of any other antidepressant or alcohol use disorder treatment.
These promising results suggest that we should test MAP4343 in people as a potential treatment for alcohol use disorder, says study senior author Candice Contet, PhD, associate professor in the Department of Molecular Medicine at Scripps Research.
The first author was Giovana Macedo, PhD, a postdoctoral research associate in the Contet lab during the study.
Researchers estimate that more than 100 million people around the world have an alcohol use disorder, and that it accounts for more than five percent of the total global burden of disease and injury. There is a strong need for better treatments since current options, which include the drug naltrexone, usually fail to prevent a relapse.
Traditionally, researchers have sought to treat alcohol use disorder by blocking the rewarding effects of drinking alcohol as naltrexone does or by reversing the anxiety and malaise that arise after alcohol withdrawal and promote relapse. However, recent studies of rodent and human brains have found evidence that alcohol use disorder can disrupt the normal production and/or regulation of key structural proteins in brain cells. These proteins include tubulin, the chief constituent of structures called microtubules, which cells use for a variety of functions including cell division and the internal transport of molecules. Precisely how disruptions to tubulin and microtubules relate to alcohol use isn't yet clear, but the available evidence suggests that these disruptions help sustain alcohol dependency so that reversing them could offer a more effective treatment strategy.
MAP4343 plausibly could fill this treatment role, since it is known to promote the assembly of tubulin proteins into microtubules. Preclinical studies also have found that MAP4343 has antidepressant properties, and its developer MAPREG, a French biotech company, is now testing it in clinical trials in patients with depression.
In the new study, the team tested MAP4343 on mice that modeled alcohol use disorder. In this standard model, intermittent exposure to alcohol vapor creates a state of dependency, such that the animals consume more and more alcohol when given a happy hour-like opportunity to drink every day and within a few weeks are getting to D.U.I. levels of intoxication voluntarily. However, when treated for six weeks with escalating doses of MAP4343, alcohol-dependent mice reduced their average daily consumption to around the levels seen in non-dependent control mice, which were relatively unaffected by the treatment. MAP4343 also normalized blood levels of the stress hormone corticosterone, which are lower in alcohol-dependent animals forced to abstain from alcohol drinking.
Contet and her colleagues conclude that MAP4343 should also be clinically tested against alcohol use disorder.
Understanding MAP4343's precise mechanism of action is another key remaining goal. In this study, the researchers found that alcohol-dependent mice experiencing alcohol withdrawal have unusually low levels of a modified form of tubulin (called acetylated -tubulin) in the medial prefrontal cortex. This brain region is known to help regulate alcohol consumption and is often weakened in alcohol use disorder.
Tubulin acetylation is known to change the mechanical properties of microtubules and it is possible that MAP4343 works against excessive alcohol drinking by reversing this change, Contet says. That is something we now intend to investigate.
Chronic MAP4343 reverses escalated alcohol drinking in a mouse model of alcohol use disorder was co-authored by Giovana Macedo, Max Kreifeldt, Scott Goulding, Agbonlahor Okhuarobo, Harpreet Sidhu, and Candice Contet, all of Scripps Research.
The research was funded in part by the National Institutes of Health (AA006420, AA026685, AA027636, AA027372).
Neurological Disorders Translational Medicine Contet, Candice
Most recent headlines
06/10/2025
France T l visions, France's leading broadcaster, has received the 2025 EBU ...
04/09/2025
Monumental Sports & Entertainment (MSE), in collaboration with Dalet, has been a...
30/08/2025
WASHINGTON The Federal Communications Commission has adopted its FY 2025 Regulatory Fees Order that establishes the regulatory fee rates for the broadcast stati...
29/08/2025
Australian Red Cross and SBS launch training to help workplaces in the fight aga...
29/08/2025
The National Film and Video Foundation (NFVF), an agency of the Department of Sp...
29/08/2025
L3Harris Technologies has concentrated decades of expertise across the entire enterprise to develop affordable and reliable best-of-breed solutions to rapidly c...
29/08/2025
BURBANK, Calif. The CW Network and the Pac-12 Conference have announced a new media rights deal that will extend their broadcast partnership beginning with the ...
29/08/2025
NEW YORK Gracenote has released a new analysis of its global video dataset showing that the number of FAST channels grew nearly 14% from Q1 2025 and 76% since 2...
29/08/2025
SAN JOSE, Calif. Harmonic has announced a series of improvements to its live sports streaming solution that the company said will improve fan engagement, protec...
29/08/2025
NEW YORK and LOS ANGELES Fox Corp. and YouTube TV last night announced a renewal of the full portfolio of Fox networks, including Fox News Channel, Fox Business...
29/08/2025
Budapest, Hungary, August 2025 - The integration of Microsoft Teams Rooms (MTR) with Lightware's Taurus universal matrix switchers delivers a new level of f...
29/08/2025
Frequency, the engine behind many of the world's best-known streaming television channels, today announced it will launch Studio Live, a next-generation uni...
29/08/2025
In an era when AI and cyber resilience are essential, Scality will mark the 10th anniversary of Scality Day on October 16, 2025 in Paris. This flagship global e...
29/08/2025
Disguise's In-House Creative and Technical Teams Pre-Visualised, Programmed and Delivered Content for the Experience, All Powered by EX 3+
Technology solu...
29/08/2025
Disguise will be demonstrating the latest workflows for TV, film and live events on a number of partner booths at the show
Disguise, the industry-leading tech...
29/08/2025
STOCKHOLM, Sweden Accedo will showcase Accedo Compose, its AI agent-powered modular orchestration layer that assists streaming providers in transitioning client...
29/08/2025
LOS ANGELES Cineverse has announced that it is working with Xperi to bring four of its streaming channels to automobiles for the first time as part of the DTS A...
29/08/2025
DALLAS & ATLANTA Gray Media has announced an agreement with the sports streaming service Victory+ to simulcast 17 Dallas Stars NHL games in 15 television market...
29/08/2025
NEW YORK AND CULVER CITY Comcast NBCUniversal and Amazon have announced new and extended distribution agreements that will expand the content available on their...
29/08/2025
FOOTHILL RANCH, Calif. RED Digital Cinema will feature its Cine-Broadcast Module supporting live broadcast workflows during IBC2025, Sept. 12-15, at the RAI Ams...
29/08/2025
29 Aug 2025
Kyivstar Rings Opening Bell at Nasdaq Marking Landmark Listing and ...
29/08/2025
More than half of all NFL games live on Sky for the first timeFriday 29 August 2025
Sky Sports has announced a new three-year deal with the NFL, extending its ...
29/08/2025
Back to All News
RIV4LRIES: The Trailer of the New Series With Samuele Carrino ...
29/08/2025
Get ready for an inspiring and emotional insight into the world of competitive Irish dancing with My Story: Tomi Champion of the World airing on RT 2 this monda...
29/08/2025
RT has today announced that David McCullagh is to be the new presenter of RT Radio 1's flagship Today programme, which airs every weekday at 10am, replaci...
28/08/2025
By Kristin Feeley, Director, Documentary Film & Artist Programs
If you want to tell untold stories, if you want to give voice to the voiceless, you've got ...
28/08/2025
Directed by Steven Bognar and Julia Reichert, Sundance Institute-supported Amer...
28/08/2025
Corridos have been a cornerstone of M sica Mexicana for generations, telling stories rooted in everyday life. Now, a new chapter is taking shape: motivational c...
28/08/2025
Los corridos han sido un pilar de la M sica Mexicana durante generaciones, contando historias enraizadas en la vida cotidiana. Ahora, un nuevo cap tulo est tom...
28/08/2025
Earlier this month, we promised our Verano Forever party would bring the heat, a...
28/08/2025
L3Harris will provide the Polish F-16V fleet with the Viper Shield electronic warfare system as part of an upgrade program....
28/08/2025
Bilbao, August 26, 2025 - AgileTV, an international television and video technol...
28/08/2025
Ken Wilkinson is an Emmy Awards nominated New York audio engineer who specialises in production sound mixing for film, commercial, episodic and documentary work...
28/08/2025
NEW YORK FuboTV today announced that it will launch Fubo Sports, a skinny bundle that focuses on sports with a subscription price of $56 monthly....
28/08/2025
NEVADA City, Calif. At IBC2025, Sept. 12-15 at the RAI Amsterdam, Telestream will debut its new Global Ingest strategy, introducing a next-generation ingest arc...
28/08/2025
Dr. Rhoda Bernard Releases Groundbreaking Debut Book on Accessible Arts Educatio...
28/08/2025
TAG Video Systems, the leader in software-based IP end-to-end workflow monitoring, deep probing, and real-time visualization, has named Oliver Gappa as Sales Di...
28/08/2025
AI-based voice enhancement will be among a series of innovations making their IBC 2025 debut on the DHD stand B46 in Hall 8 at the RAI Amsterdam Convention Cent...
28/08/2025
Telef nica Servicios Audiovisuales (TSA), the leading system integrator and service provider in the media sector in Spain, with the support of Appear, the globa...
28/08/2025
To fully immerse sailing fans in the world's biggest offshore yacht race, production company, Optical Media turned to LiveU's On-site Production solutio...
28/08/2025
Working with Calrec on its most recent overhaul, radio and television broadcaster, WNED has migrated to a fully IP infrastructure with multiple Type R consoles,...
28/08/2025
Cleeng, the Subscriber Retention Management (SRM ) inventor, has unveiled Cleeng Pro, the first-ever direct-to-consumer (D2C) subscription management platform t...
28/08/2025
Zixi, the industry leader in live broadcast-quality video over IP, today announced that French media distribution platform OKAST has selected Zixi to enable rel...
28/08/2025
Solution offers a streamlined, speaker-free architecture to optimize integration with premium external loudspeakers and advanced loudness metering
Nixer Pro Au...
28/08/2025
Cinegy, the premier provider of software-defined television technology, has announced a strategic partnership with Vision One Touch Film Production Services L.L...
28/08/2025
Telestream, a global leader in media workflow technologies, will debut its new Global Ingest strategy at IBC2025, introducing a next-generation ingest architect...
28/08/2025
Tier 1 operator selects Broadpeak to power high-performance, unified CDN solution across Norway, Sweden and Finland
Broadpeak, a leader in streaming and moneti...
28/08/2025
Leading video software provider, Synamedia, today announced that 24 Frames Digital, one of India's leading live event streaming service providers, has chose...
28/08/2025
Meet VisualOn at IBC2025: See What's Next in AI-Powered Video Streaming Join VisualOn at IBC2025 and discover how our AI-driven Optimizer and advanced media...
Experimental anti-depression drug may also be useful in treating alcohol use disorder Investigational, clinical-stage antidepressant MAP4343 shown to reduce alcohol intake in a mouse model of alcoholism.
